Economic Benefit for Lifestyle Modification in Prediabetes

This article originally appeared here.
Share this content:
Economic Benefit for Lifestyle Modification in Prediabetes
Economic Benefit for Lifestyle Modification in Prediabetes

WEDNESDAY, March 15, 2017 (HealthDay News) -- For individuals with prediabetes, participation in lifestyle modifications such as the National Diabetes Prevention Program (DPP) is associated with economic benefit, according to a study published online Feb. 13 in Population Health Management.

Tamkeen Khan, Ph.D., from the American Medical Association in Chicago, and colleagues used individual-level claims data to identify adults with prediabetes, track whether they developed diabetes, and compare medical expenditures for those with or without newly diagnosed diabetes. The authors examined the impact of reducing diabetes risk by participation in an evidence-based lifestyle change program on medical care expenditures and return on investment (ROI).

The researchers found that those who developed diabetes had annual expenditures that were nearly one-third higher in subsequent years relative to those who did not transition from prediabetes to diabetes, with an average difference of $2,671 per year. The three-year ROI from participation in the National DPP was estimated to be as high as 42 percent at that cost differential.

"The results show the importance and economic benefits of participation in lifestyle intervention programs to prevent or delay the onset of type 2 diabetes," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »